OP-36 - Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse
| Autor: | Kose, F., Alemdaroglu, S., Mertsoylu, H., Besen, A., Guler, O., Simsek, S., Erbay, G., Onal, C., Celik, H. |
|---|---|
| Zdroj: | In Leukemia Research October 2019 85 Supplement 1:S34-S34 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect